Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Urethritis screening

Introduction

Overview

Overview

High-risk individuals should be screened for sexually transmitted diseases. The U.S. Preventive Service Task Force (USPSTF) developed recommendations for the screening of for Chlamydia trachomatis and N. gonorrhea.

Screening

Screening

According to the U.S. Preventive Service Task Force (USPSTF), screening for sexually transmitted disease is recommended as outlined below for Chlamydia trachomatis and N. gonorrhea.[1][2]

Chlamydia trachomatis
Population Recommendations
Women
  • Sexually active women under 25 years of age
  • Sexually active women aged 25 years and older if at increased risk
    • Prior history of sexually transmitted infection
    • A new sex partner
    • More than one sex partner
    • A sex partner with concurrent partners
    • A sex partner who has a sexually transmitted infection
  • Retest 3 months after treatment.
Men
  • Consider screening young men in high-prevalence clinical settings or in populations with a high burden of infection (e.g., men who have sex with men)
Pregnant women
  • All pregnant women under 25 years of age
  • Pregnant women aged 25 years and older if at increased risk
  • Retest during the third trimester for women under 25 years of age or at risk
  • Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months
Men Who have Sex With Men (MSM)
  • At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use
  • Every 3 to 6 months if at increased risk
HIV positive patients
  • For sexually active individuals, screen at first HIV evaluation and at least annually
  • More frequent screening may be indicated depending on individual risk behaviors and local epidemiology
Neisseria Gonorrhea
Population Recommendations
Women
  • Sexually active women under 25 years of age
  • Sexually active women age 25 years and older if at increased risk
  • Retest 3 months after treatment.
Men Who have Sex With Men (MSM)
  • At least annually for sexually active MSM at sites of contact (urethra, rectum, pharynx) regardless of condom use
  • Every 3 to 6 months if at increased risk
Pregnant women
  • All pregnant women under 25 years of age and older women if at increased risk
  • Retest 3 months after treatment
HIV positive patients
  • For sexually active individuals, screen at first HIV evaluation and at least annually
  • More frequent screening may be indicated depending on individual risk behaviors and the local epidemiology
References

References

  1. ↑ Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 28, 2016
  2. ↑ US preventive services task forces. Gonorrhea and chlamydia screening (2014) https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/chlamydia-and-gonorrhea-screening Accessed on September 28, 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]